Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,012,347
+$22,985 QoQ
Shares Held
4,023
-11.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#2,525
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Advisors, Ltd. LLC holds $5,862,596 across 10 Drug Manufacturers - General names. ABBV ranks #4 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,191 | $1,428,521 | |
| 2 | JNJ |
Johnson & Johnson
|
4,524 | $1,148,960 | |
| 3 | AMGN |
Amgen Inc
|
2,998 | $1,085,635 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
4,023 | $1,012,347 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,345 | $558,332 | |
| 6 | PFE |
Pfizer Inc
|
11,663 | $280,845 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,319 | $166,642 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,274 | $131,027 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,012,347 | 4,023 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $989,362 | 4,549 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,019,065 | 4,460 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,024,564 | 4,425 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $815,799 | 4,395 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $910,154 | 4,344 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $703,692 | 3,960 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $773,924 | 3,919 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $763,778 | 4,453 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $800,875 | 4,398 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $661,721 | 4,270 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $648,261 | 4,349 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $603,725 | 4,481 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $697,721 | 4,378 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $701 | 5,008 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $560,460 | 4,176 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $619,379 | 4,044 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $655,410 | 4,043 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $476,337 | 3,518 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $308,292 | 2,858 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $176,844 | 1,570 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $169,688 | 1,568 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $167,904 | 1,567 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $137,165 | 1,566 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $153,553 | 1,564 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $119,084 | 1,563 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||